About
Breast Cancer Assay
Areas of Focus
Categories
DiagnosticsSan Diego & Southern California
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
8
As Collaborator
12
Total Enrollment
44,441
By Phase
PHASE2: 4PHASE1/PHASE2: 2PHASE4: 1PHASE3: 1
By Status
COMPLETED: 13RECRUITING: 4WITHDRAWN: 2UNKNOWN: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
Hover over trial bars to see details
Recent Trials
NCT05693766Collaborator
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
PHASE2Recruiting
64 participants
Started: Sep 11, 2023 · Completed: Aug 31, 2037
NCT05792150Collaborator
PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
N/ARecruiting
1,470 participants
Started: Dec 7, 2022 · Completed: Jun 30, 2035
NCT05297617Collaborator
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
PHASE2Recruiting
696 participants
Started: Oct 12, 2022 · Completed: Nov 30, 2035
NCT04031872Collaborator
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
PHASE1/PHASE2Withdrawn
Started: Jan 1, 2020 · Completed: Jan 1, 2020
NCT04129216Collaborator
The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
PHASE2Completed
30 participants
Started: Feb 20, 2019 · Completed: Nov 10, 2022
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...